1. Sales Quantity Analysis of Key Manufacturers in the Global High Content Screening Instruments Market
Sales of high-content screening instruments from major leading manufacturers have grown steadily from 2018 to 2023. PerkinElmer, Danaher, and Thermo Fisher have all shown sustained growth, with Thermo Fisher having the highest sales, from 232 units in 2018 to 290 units in 2023. Miltenyi Biotec and Logos Biosystems have shown significant growth, indicating that they have become key players in the market. In contrast, TissueGnostics has had lower sales. Overall, the market has expanded from 1388 units in 2018 to 1837 units in 2023, with the top three manufacturers accounting for nearly half of total sales.
Figure Global High Content Screening Instruments Sales Quantity (Unit) by Manufacturer (2018-2023)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
PerkinElmer | 173 | 191 | 177 | 190 | 202 | 212 |
Danaher | 194 | 209 | 200 | 221 | 232 | 248 |
Thermo Fisher | 232 | 247 | 233 | 246 | 262 | 290 |
Miltenyi Biotec | 42 | 46 | 48 | 80 | 126 | 134 |
Yokogawa | 84 | 91 | 86 | 93 | 99 | 106 |
Nikon | 157 | 165 | 155 | 163 | 172 | 189 |
Logos Biosystems | 23 | 26 | 27 | 40 | 47 | 50 |
TissueGnostics | 5 | 6 | 5 | 6 | 6 | 6 |
Others | 239 | 258 | 249 | 267 | 285 | 301 |
Total | 1388 | 1497 | 1429 | 1573 | 1716 | 1837 |
2. Revenue Analysis of Key Manufacturers in the Global High Content Screening Instruments Market
Revenues for high-content screening instruments from the major leading manufacturers have grown steadily from 2018 to 2023. PerkinElmer, Danaher, and Thermo Fisher have all shown sustained growth, with PerkinElmer leading the way with the highest revenue figures. Miltenyi Biotec has seen a significant increase in revenue, more than tripling from $12.86 million in 2018 to $40.63 million in 2023. Yokogawa and Nikon have also shown growth, albeit at a more modest pace. Logos Biosystems has shown significant growth, especially from 2020 to 2023. In contrast, TissueGnostics has had lower revenue levels. Overall, the market has expanded from $335.82 million in 2018 to $433.77 million in 2023, with the top three manufacturers accounting for more than half of the total revenue.
Figure Global High Content Screening Instruments Revenue (M USD) by Manufacturer (2018-2023)
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
PerkinElmer | 72.33 | 80.55 | 73.42 | 80.17 | 83.38 | 86.72 |
Danaher | 62.27 | 66.37 | 62.86 | 70.43 | 72.31 | 76.38 |
Thermo Fisher | 54.23 | 57.02 | 53.38 | 57.37 | 59.93 | 65.62 |
Miltenyi Biotec | 12.86 | 14.22 | 14.68 | 24.94 | 38.36 | 40.63 |
Yokogawa | 32.09 | 34.41 | 32.16 | 35.17 | 36.61 | 38.73 |
Nikon | 32.16 | 33.57 | 31.16 | 33.50 | 34.75 | 37.91 |
Logos Biosystems | 2.68 | 3.00 | 3.08 | 4.62 | 5.32 | 5.64 |
TissueGnostics | 1.28 | 1.55 | 1.31 | 1.60 | 1.55 | 1.55 |
Others | 65.91 | 70.61 | 67.25 | 73.24 | 76.79 | 80.61 |
Total | 335.82 | 361.30 | 339.31 | 381.03 | 409.00 | 433.77 |
3. Average Price Analysis of Key Manufacturers in the Global High Content Screening Instruments Market
The average price of high-content screening instruments from the leading manufacturers is slowly decreasing from 2018 to 2023. PerkinElmer, Danaher, and Thermo Fisher all show slow declines, with PerkinElmer leading with the highest average price, which drops from $418000 in 2018 to $409000 in 2023. Overall, the market average price drops from $242000 in 2018 to $236000 in 2023.
Figure Global High Content Screening Instruments Average Price (K USD/Unit) by Manufacturer (2018-2023)
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
PerkinElmer | 418 | 422 | 415 | 422 | 413 | 409 |
Danaher | 321 | 318 | 314 | 319 | 312 | 308 |
Thermo Fisher | 234 | 231 | 229 | 233 | 229 | 226 |
Miltenyi Biotec | 306 | 309 | 306 | 312 | 304 | 303 |
Yokogawa | 382 | 378 | 374 | 378 | 370 | 365 |
Nikon | 205 | 203 | 201 | 206 | 202 | 201 |
Logos Biosystems | 117 | 116 | 114 | 115 | 113 | 113 |
TissueGnostics | 256 | 258 | 263 | 266 | 259 | 258 |
Others | 276 | 274 | 270 | 274 | 269 | 268 |
Total | 242 | 241 | 237 | 242 | 238 | 236 |
4. Top 3 High Content Screening Instruments Manufacturer Market Share in 2022
The market concentration among the top manufacturers in the High Content Screening Instruments market in 2022 is moderate, the competitive environment is fierce, and the products of other manufacturers have the potential for growth and diversification. The top three manufacturers together account for 52.72% of the market share, and “others” account for 47.28% of the market share.
Figure Top 3 High Content Screening Instruments Manufacturer Market Share in 2022
5. PerkinElmer
5.1 PerkinElmer Details
Table PerkinElmer Basic Information, Manufacturing Base
Item | Description | |
1 | Company Name | PerkinElmer |
2 | Website | www.perkinelmer.com.cn |
3 | Established Time | 1937 |
4 | Headquarters | USA |
5 | Market Distribution | Worldwide |
5.2 PerkinElmer Major Business
PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and various other services. The company’s major products include cytogenetic reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography instruments, molecular spectroscopy, newborn screening instruments, and thermal analysis instruments. It offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. PerkinElmer also offers cord blood and tissue banking, laboratory and research services. Its products are used in atomic spectroscopy, cell imaging and analysis, chromatography, analysis and detection, DNA/RNA isolation, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others.
5.3 PerkinElmer High Content Screening Instruments Product Introduction
Table PerkinElmer High Content Screening Instruments Product Introduction
Operetta CLS High Content Analysis System Operetta® CLS™ is a high throughput microplate imager for high-content analysis (HCA). It can acquire, analyze and manage fluorescence, brightfield and digital phase contrast images. The combination of high power LED excitation with fast, precise mechanics and one large format sCMOS camera enables fast imaging. Controlled by Harmony™ software it offers a seamless workflow, for reliable discrimination of phenotypes even in complex cellular models. |
5.4 PerkinElmer High Content Screening Instruments Market Performance
PerkinElmer’s high-content screening instrument sales have increased steadily from 2018 to 2023. Sales have generally increased from 173 units in 2018 to 212 units in 2023, but with some fluctuations. The average price per unit has changed slightly, starting at $418000 in 2018 and decreasing to $409000 in 2023. Revenue has increased from $72.33 million in 2018 to $86.72 million in 2023, indicating a positive trend in financial performance. Gross margin has remained relatively stable, starting at 55.05% in 2018 and decreasing slightly to 53.95% in 2023, indicating effective cost management and profitability.
Table PerkinElmer High Content Screening Instruments Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
PerkinElmer | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Sales (Unit) | 173 | 191 | 177 | 190 | 202 | 212 |
Price (K USD/Unit) | 418 | 422 | 415 | 422 | 413 | 409 |
Revenue (M USD) | 72.33 | 80.55 | 73.42 | 80.17 | 83.38 | 86.72 |
Gross (M USD) | 39.82 | 43.90 | 40.11 | 43.30 | 44.90 | 46.79 |
Gross Margin | 55.05% | 54.50% | 54.63% | 54.00% | 53.85% | 53.95% |
The growth rate is positive 10.40% in 2018-2029, then falls to -7.33% in 2020. The market then achieves a strong growth rate of 7.34% in 2021, and despite a slight decline in the following years, it remains in the positive zone, with a growth rate expected to reach 4.95% by 2023.
Figure PerkinElmer Sales and Growth Rate
PerkinElmer’s revenue from high-content screening instruments has grown steadily from 2018 to 2023. Revenues generally increase from $72.33 million in 2018 to $86.72 million in 2023, but with some fluctuations. Global market share decreases slightly from 22.30% in 2019 to 19.99% in 2023.
Figure PerkinElmer Revenue Market Share 2018-2023
5.5 PerkinElmer Developments/Updates
New Mountain Capital Announces Intent to Acquire PerkinElmer’s Applied, Food and Enterprise Services Businesses for up to $2.45 Billion
August 1, 2022
New Mountain Capital, a growth-oriented investment firm with over $37 billion in assets under management, announced that it has entered into a definitive agreement with the intention to acquire PerkinElmer’s Applied, Food and Enterprise Services businesses, a carve-out from the Discovery & Analytical Solutions segment of PerkinElmer, Inc. (NYSE: PKI), for up to $2.45 billion in total consideration.
The business being acquired includes PerkinElmer’s leading OneSource laboratory and field services, along with a portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables and reagents that serve the biopharma, food, environmental & safety and applied end markets. The PerkinElmer brand will be transferred with the business, and the transaction is expected to close in the first quarter of 2023, subject to regulatory approvals and other customary closing conditions.
